openPR Logo
Press release

Harvard Medical School presents HMS mobile

10-14-2009 07:36 PM CET | Health & Medicine

Press release from: Harvard Medical School

/ PR Agency: Priroda I
First application will provide critical information on the H1N1 pandemic in advance of an expected surge of infections beginning in October


Boston, MA, October 7th, 2009 – The Harvard Health Publications Division of Harvard Medical School announced today that it will launch a new program called HMS Mobile to deliver a series of iPhone Applications aimed at promoting public health. The first such application will focus on the H1N1 flu pandemic and is scheduled for release to the public in early October. These applications will leverage Harvard Medical School’s extensive knowledge along with its long-standing expertise in publishing health information for the general public. The School’s goal is to provide the public with the best available information on public health-related issues, including practical advice on how to reduce risks and how to respond in the event of a public health threat.

Professor Anthony L. Komaroff, professor of medicine at Harvard Medical School and editor-in-chief of Harvard Health Publications commented, “Increasingly, people are receiving information through mobile devices. No one carries printed publications or their computers with them wherever they go, but our mobile devices are always with us to give us answers—anytime, anywhere. People who have a question about their health want an answer now. Particularly with something like a fast-moving pandemic, “now” is when you need information. With this initiative, Harvard Medical School will for the first time publish health information for the general public using mobile devices. The iPhone’s emergence as a device that is deeply integrated into users’ daily lives offers the chance to reach millions of people around the world, improving our ability to respond to urgent public health challenges.”

The first application to be launched will be focused on the H1N1 flu. Since the first outbreak of the so-called “swine flu” in April 2009 there have been over 180,000 cases of infection globally according to the World Health Organization.

Professor Komaroff noted, “The H1N1 pandemic presents a significant public health threat. The White House estimates that the H1N1 flu will be more severe than the regular flu. Flu epidemics are hard to predict. Any estimates may be too optimistic or too pessimistic. However, we could be facing the most serious pandemic in a generation. Nothing is more important at this time than making sure the public is informed and prepared.”

The planned iPhone application on the H1N1 flu will include science-based information on the state of the pandemic’s spread; practical steps people can take to mitigate their risk of infection; key symptoms to watch for; and how to act in case of a suspected infection. In addition, the application will provide businesses with specific information on how to best prepare their enterprises for managing through the pandemic. This business-focused content was developed in collaboration with Harvard Business School.

Michael E. Porter, Harvard Professor, internationally-known authority on health care strategy, and Harvard Health Publications advisor, added, “Our nation’s response to H1N1 is going to be a real test of our ability to deal with nation-wide systemic threats. Utilizing the power of mobile technologies is going to be a critical component in our response profile. These tools offer unprecedented ability to put information in the palm of people’s hands at the very moment when it can make the most difference – when a first symptom is spotted, when a co-worker gets sick, when a family member is in need of care. That can make the difference between a destructive, panicked reaction and a thoughtful, preventative response.”

HMSMobile, which was developed in cooperation with The Imagine Network as a strategic partner, represents the commitment of Harvard Medical School’s doctors and scientists to provide people with knowledge and skills that will improve their health. Over time HMSMobile plans to expand its offerings to include content for additional platforms beyond the iPhone series, as different mobile devices add functionality that allows for similar integration.

About Harvard Medical School and Harvard Health Publications:

Harvard University established the medical school in 1782. The mission of Harvard Medical School is to create and nurture a diverse community of the best people committed to leadership in ending human suffering caused by disease. It encompasses 17 affiliated hospitals and research institutions. Each year, more than 10,000 faculty members train hundreds of medical students and thousands of resident physicians and research fellows. Harvard doctors have developed a broad range of medical breakthroughs, scientific discoveries and innovations for which they have received numerous awards, including 15 Nobel prizes. Harvard Health Publications is a division of Harvard Medical School responsible for creating information about health and medicine for the general public—newsletters, special health reports, books, magazine articles, newspaper columns, and information for Web sites (www.health.harvard.edu).


About The Imagine Network

The Imagine Network is a global consulting firm facilitating growth for prominent corporations, business units and governments through competitive strategy combined with cutting edge utilization of ICT platforms. It embodies a group of organizations active in the areas of strategy, entrepreneurship, technology ventures, and non-profit and governmental organizations.

Press contact:
Danni Matijaca
danni@hmsmobile.com
www.hmsmobile.com
+385 21 323 172
+385 91 4444 538
Priroda I PR agency
Dinka Simunovica 14
21 000 Split
Croatia

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Harvard Medical School presents HMS mobile here

News-ID: 100265 • Views:

More Releases for H1N1

Rise In R&D Investments Drives The H1N1 Vaccine Market: A Significant Driver Pro …
The H1N1 Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the H1N1 Vaccine Market Size and Projected Growth Rate? The market size of the H1N1 vaccine has significantly expanded in the recent past. Its growth is projected to rise from $3.33 billion in
H1N1 (Swine Influenza) - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on H1N1 (Swine Influenza) Pipeline landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The H1N1 flu (swine flu) is primarily caused by the H1N1 strain of the flu (influenza) virus. It is a communicable viral illness causing upper and lower respiratory tract infections. Swine flu H1N1 infects the cells that line
H1N1 Vaccines Market Opportunity Analysis, 2018 – 2026
H1N1 influenza virus causes viral disease, commonly known as swine flu, which mostly affects the respiratory system. Swine flu is characterized by infection from H1N1 strain. Symptoms of H1N1 flu are fever, cough, sore throat, runny or stuffy nose, watery and red eyes, body aches, headache, fatigue, and diarrhea. H1N1 spreads through contact with contaminated air or geographical locations infected with virus. H1N1 infection may worsen other chronic respiratory conditions
H1N1 Vaccination Market - Global Industry Analysis 2023
H1N1 influenza virus or swine H1N1 virus is a causative agent of infectious disease caused in human beings known as H1N1 or commonly referred as swine flu. The H1N1 virus mainly affects the respiratory system including nose, lungs and throat of the infected person. In addition to human, H1N1 virus affects various species such as birds, swine, horses etc. The H1N1 influenza virus caused a worldwide pandemic in the recent
H1N1 Vaccines Market Rugged Expansion Foreseen by 2021
The H1N1 Vaccines Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one
Europe H1N1 Vaccines Market 2017
Latest market study on " Europe H1N1 Vaccines Market Report: 2017 " available with Single User Europe USD 3900 at OrbisResearch.com The H1N1 Vaccines Market report covers the present scenario and the growth prospects of the Europe H1N1 Vaccines market for 2017-2022 The report covers the market landscape and its growth prospects over the coming years. To calculate the market size , market share, market growth, market analysis , market